Found 147 articles for: "actinic keratosis"
2020 IDEOM Annual Meeting: Actinic Keratosis Stakeholders Survey Identifies Gaps in Research and Care
February 2022 | Volume 21 | Issue 2 | Original Article | 128 | Copyright © February 2022
This is a report of the survey results from the International Dermatology Outcome Measures (IDEOM) actinic keratosis (AK) workgroup. The purpose of the survey was to compile a list of gaps within AK c...
Read MoreArtificial Intelligence in the Evaluation of Telemedicine Dermatology Patients
February 2022 | Volume 21 | Issue 2 | Original Article | 191 | Copyright © February 2022
Background: Background: Early detection of malignant skin lesions reduces morbidity. There is increased need for a telemedicine triage tool to prioritize patients who require in-perso...
Read MoreUse of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review
January 2022 | Volume 21 | Issue 1 | Original Article | 60 | Copyright © January 2022
Background: Actinic Keratosis (AK) is a premalignant lesion that can progress to cutaneous squamous cell carcinoma (cSCC). Topical 5-Fluorouracil (5-FU) and imiquimod have been used f...
Read MoreAminolevulinic Acid 20% Solution Combined With Photodynamic Therapy for Treatment of Actinic Keratoses: A Review
November 2021 | Volume 20 | Issue 11 | Original Article | 1239 | Copyright © November 2021
Actinic keratoses (AK) are lesions with potential to transform into nonmelanoma skin cancers. Numerous methods are available for treatment of AK. Here, we review clinical trial data on the use of phot...
Read MoreINDIVIDUAL ARTICLE: Safety and Tolerability of Topical Agents for Actinic Keratosis: A Systematic Review of Phase 3 Clinical Trials
October 2021 | Volume 20 | Issue 10 | Supplement Individual Articles | s4s4 | Copyright © October 2021
Background: Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple opti...
Read MoreINDIVIDUAL ARTICLE: The Importance of Local Tolerability and Duration of Therapy in Topical Actinic Keratosis Treatment
October 2021 | Volume 20 | Issue 10 | Supplement Individual Articles | s3s3 | Copyright © October 2021
Actinic keratoses (AK) are among the most common dermatologic presentations, with estimates suggesting that they account for approximately 15 percent of dermatologic diagnoses in the US.1 Incidence of...
Read MoreFULL SUPPLEMENT: TIRBANIBULIN 1% OINTMENT FOR ACTINIC KERATOSIS LESS PAIN, MORE GAIN
October 2021 | Volume 20 | Issue 10 | Department | s3s | Copyright © October 2021
Topical agents for actinic keratosis (AK), along with cryotherapy and phototherapy, are the most commonly used therapies for areas of skin with multiple AKs. Multiple options for the topical treatment...
Read MoreAdvances and Considerations in the Management of Actinic Keratosis: An Expert Consensus Panel Report
August 2021 | Volume 20 | Issue 8 | Original Article | 888 | Copyright © August 2021
Background: Actinic Keratosis (AK) is a potentially pre-malignant tumor with a poorly defined risk of progression to invasive squamous cell carcinoma (SCC). Because of the typical nee...
Read MoreRacial/Ethnic Variations in Acne: Implications for Treatment and Skin Care Recommendations for Acne Patients With Skin of Color
July 2021 | Volume 20 | Issue 7 | Original Article | 716 | Copyright © July 2021
Background: Acne vulgaris is among the most common dermatologic diagnoses observed, including skin color (SOC) populations. This project sought to help clarify the existing published ...
Read MoreIngenol Mebutate as Treatment of Squamous Cell Carcinoma In Situ: A Case Series
February 2021 | Volume 20 | Issue 2 | Original Article | 169 | Copyright © February 2021
Ingenol mebutate (IM) is a novel drug currently only FDA-approved for the treatment of actinic keratosis. However, it has been extensively used off-label to treat multiple other skin disorders. In rec...
Read MoreIngenol Mebutate and the Treatment of Actinic Keratosis
January 2021 | Volume 20 | Issue 1 | Editorials | 102 | Copyright © January 2021
Actinic keratoses (AKs) are common skin lesions association with increased exposure to ultraviolet radiation; these lesions have the potential to transform into squamous cell carcinomas (SCCs).1<...
Read MoreTolerability of Six Months Indirect Cold (Physical) Plasma Treatment of the Scalp for Hair Loss
December 2020 | Volume 19 | Issue 12 | Original Article | 1177 | Copyright © December 2020
Androgenetic alopecia (AGA) is a chronic form of hair loss. Cold atmospheric (physical) plasma (CAP) is partly ionized gas with various widely researched effects on living tissues. CAP is an emerging ...
Read MoreTirbanibulin Ointment 1% as a Novel Treatment for Actinic Keratosis: Phase 1 and 2 Results
November 2020 | Volume 19 | Issue 11 | Original Article | 1093 | Copyright © November 2020
Background: Current field-directed treatments of actinic keratosis (AK), a pre-malignant condit...
Read MoreSequential Treatment of Actinic Keratosis and Photoaging by Daylight PDT and Injectable NASHA Gel as Skin Booster
November 2020 | Volume 19 | Issue 11 | Original Article | 1065 | Copyright © November 2020
Introduction: Actinic keratosis (AK) is a common intraepithelial atypical proliferation of keratinocytes that might progress into invasive squamous cell carcinoma.
Metho...
Read MoreThe Potential for Teledermatology in Managing and Diagnosing Patients With Cutaneous Lymphomas
November 2020 | Volume 19 | Issue 11 | Features | 1125 | Copyright © November 2020
Rapid Evolution of a Squamous Cell Carcinoma In Situ to Locally Invasive With Perineural Involvement
November 2020 | Volume 19 | Issue 11 | Case Reports | 1110 | Copyright © November 2020
We present a case of rapidly progressing squamous cell carcinoma in situ (SCCis) with progression to aggressive SCC. An elderly gentleman with multiple medical comorbidities presented with a left zygo...
Read MoreARTICLE: The 1440 nm and 1927 nm Nonablative Fractional Diode Laser: Current Trends and Future Directions
August 2020 | Volume 19 | Issue 8 | Supplement Individual Articles | s3 | Copyright © August 2020
Clinical characteristics of skin exposed to ultraviolet and infrared radiation include dryness, dyschromia, laxity, roughness, sallowness, scaling, telangiectasia, and wrinkles. Fractional photothermo...
Read MoreReal-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis
August 2020 | Volume 19 | Issue 8 | Original Article | 756 | Copyright © August 2020
Background: Real-world data for actinic keratosis treatment in the United States is lacking.
Objectives: To understand real-world treatment patterns for actinic...
Read MoreUtilization of an Online Cash-Pay Pharmacy for Topical 5-Fluorouracil Prescriptions in Older Patients
May 2020 | Volume 19 | Issue 5 | Original Article | 539 | Copyright © May 2020
Background: High cost of prescription medications presents a challenging issue for older patients with multimorbidities. Topical 5-fluorouracil (5-FU) is an effective treatment for ac...
Read MoreTreating Field Cancerization by Ablative Fractional Laser and Indoor Daylight: Assessment of Efficacy and Tolerability
April 2020 | Volume 19 | Issue 4 | Case Reports | 425 | Copyright © April 2020
Objective: To assess if ablative fractional laser combined with indoor daylight photodynamic therapy are effective and safe for the treatment of skin field cancerization associated wi...
Read More
